Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04937868 · ClinicalTrials.gov registry record

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

A clinical trial of Hip Injuries and Pelvic Fracture, sponsored by University of California, Los Angeles.

Recruiting
Registry status
12,000
Enrollment target
1
Study location

NCT04937868 is a study of Hip Injuries and Pelvic Fracture that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 12,000 participants, above the 407-participant average among 7 other Hip Injuries trials with a reported enrollment target (2848% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04937868, a study of Hip Injuries and Pelvic Fracture, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
12,000 participants
Enrollment target
1
Study location

Study Summary

Unrecognized abdominal and pelvic injuries can result in catastrophic disability and death. Sporadic reports of "occult" injuries have generated concern, and physicians, fearing that they may miss such an injury, have adopted the practice of obtaining computed tomography on virtually all patients with significant blunt trauma. This practice exposes large numbers patients to dangerous radiation at considerable expense, while detecting injuries in a small minority of cases. Existing data suggest that a limited number of criteria can reliably identify blunt injury victims who have "no risk" of abdominal or pelvic injuries, and hence no need for computed tomography (CT), without misidentifying any injured patient. It is estimated that nationwide implementation of such criteria could result in an annual reduction in radiographic charges of $75 million, and a significant decrease in radiation exposure and radiation induced malignancies. This study seeks to determine whether "low risk" criteria can reliably identify patients who have sustained significant abdominal or pelvic injuries and safely decrease CT imaging of blunt trauma patients. This goal will be accomplished in the following manner: All blunt trauma victims undergoing computed tomography of the abdomen/pelvis in the emergency department will undergo routine clinical evaluations prior to radiographic imaging. Based on these examinations, the presence or absence of specific clinical findings (i.e. abdominal/pelvic/flank pain, abdominal/pelvic/flank tenderness, bruising abrasions, distention, hip pain, hematuria, hypotension, tachycardia, low or falling hematocrit, intoxication, altered sensorium, distracting injury, positive FAST imaging, dangerous mechanism, abnormal x-ray imaging) will be recorded for each patient, as will the presence or absence of abdominal or pelvic injuries. The clinical findings will serve as potential imaging criteria. At the completion of the derivation portion of the study the criter

Interventions

  • OTHER There are no interventions associated with this study

Study Locations (1)

California

  • Ronald Reagan Hospital - Los Angeles

Trial Details

FieldValue
Enrollment Target 12,000 participants
Start Date 2018-01-15
Est. Completion 2027-06-15

What the Registry Record Tells You About NCT04937868

The ClinicalTrials.gov registry entry for NCT04937868 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 12,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 407-participant average among 7 other Hip Injuries trials with a reported enrollment target (2848% higher). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Hip Injuries appearing as the primary indexed condition, and to 1 intervention - of which There are no interventions associated with this study is the first listed.

NCT04937868 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04937868 about?

NCT04937868 is a clinical study titled "Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients". Unrecognized abdominal and pelvic injuries can result in catastrophic disability and death. Sporadic reports of "occult" injuries have generated concern, and physicians, fearing that they may miss such an injury, have adopted the practice of obtaining computed tomography on virtually all patients wi...

What is the current status of trial NCT04937868?

This trial is currently recruiting. The enrollment target is 12,000 participants. The study started on 2018-01-15. Estimated completion is 2027-06-15.

What conditions does trial NCT04937868 study?

This clinical trial studies the following conditions: Hip Injuries, Pelvic Fracture, Renal Injury, Lumbar Spine Injury, Abdominal Injury.

What interventions are being tested in trial NCT04937868?

The interventions under investigation include: There are no interventions associated with this study (OTHER).

Who is sponsoring clinical trial NCT04937868?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04937868 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.